US FDA grants tentative approval to Liquidia's inhaled blood pressure drug

Liquidia

19/08/2024 11:05

Aug 19 (Reuters) - The U.S. Food and Drug Administration
has granted tentative approval to Liquidia Corp's  LQDA.O  drug
to treat high blood pressure in the lungs, and for patients with
a type of lung disorder, the company said on Monday.

 (Reporting by Sneha S K and Sriparna Roy in Bengaluru; Editing
by Tasim Zahid)
 ((Sneha.SK@thomsonreuters.com;))